494 related articles for article (PubMed ID: 12610805)
21. Evaluation of small bowel injury in patients with rheumatoid arthritis by capsule endoscopy: effects of anti-rheumatoid arthritis drugs.
Sugimori S; Watanabe T; Tabuchi M; Kameda N; Machida H; Okazaki H; Tanigawa T; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Oshitani N; Koike T; Higuchi K; Arakawa T
Digestion; 2008; 78(4):208-13. PubMed ID: 19142000
[TBL] [Abstract][Full Text] [Related]
22. [Allergic manifestations of systemic lupus erythematosus].
Diumenjo MS; Lisanti M; Vallés R; Rivero I
Allergol Immunopathol (Madr); 1985; 13(4):323-6. PubMed ID: 4083230
[TBL] [Abstract][Full Text] [Related]
23. Rheumatoid arthritis in Sweden. Drug prescriptions, costs, and adverse drug reactions.
Blomqvist P; Feltelius N; Ekbom A; Klareskog L
J Rheumatol; 2000 May; 27(5):1171-7. PubMed ID: 10813283
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
[TBL] [Abstract][Full Text] [Related]
25. The detecting and clinical value of anti-cyclic citrullinated peptide antibodies in patients with systemic lupus erythematosus.
Qing YF; Zhang QB; Zhou JG; Yuan GH; Wei J; Xing Y; Liu JP; Jiang L; Chen JP
Lupus; 2009 Jul; 18(8):713-7. PubMed ID: 19502267
[TBL] [Abstract][Full Text] [Related]
26. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares.
Amoura Z; Combadiere C; Faure S; Parizot C; Miyara M; Raphaël D; Ghillani P; Debre P; Piette JC; Gorochov G
Arthritis Rheum; 2003 Dec; 48(12):3487-96. PubMed ID: 14673999
[TBL] [Abstract][Full Text] [Related]
27. Antibiotic allergy in systemic lupus erythematosus: a case-control study.
Petri M; Allbritton J
J Rheumatol; 1992 Feb; 19(2):265-9. PubMed ID: 1629825
[TBL] [Abstract][Full Text] [Related]
28. Metabolic syndrome in patients with systemic lupus erythematosus from Southern Spain.
Sabio JM; Zamora-Pasadas M; Jiménez-Jáimez J; Albadalejo F; Vargas-Hitos J; Rodríguez del Aguila MD; Hidalgo-Tenorio C; Gonzalez-Gay MA; Jimenez-Alonso J
Lupus; 2008 Sep; 17(9):849-59. PubMed ID: 18755869
[TBL] [Abstract][Full Text] [Related]
29. Rituximab infusion-related adverse event rates are lower in patients with systemic lupus erythematosus than in those with rheumatoid arthritis.
Conti F; Ceccarelli F; Perricone C; Alessandri C; Conti V; Massaro L; Truglia S; Spinelli FR; Spadaro A; Valesini G
Rheumatology (Oxford); 2011 Jun; 50(6):1148-52. PubMed ID: 21278072
[TBL] [Abstract][Full Text] [Related]
30. Retroviral risk factors in patients with autoimmune disease.
Drevlow BE; Schilling EM; Khabbaz RF; Kaplan JE; Fukuda K; Sinacore J; Ramsey-Goldman R
J Rheumatol; 1996 Mar; 23(3):428-31. PubMed ID: 8832977
[TBL] [Abstract][Full Text] [Related]
31. Plasma adiponectin in patients with active, early, and chronic rheumatoid arthritis who are steroid- and disease-modifying antirheumatic drug-naive compared with patients with osteoarthritis and controls.
Laurberg TB; Frystyk J; Ellingsen T; Hansen IT; Jørgensen A; Tarp U; Hetland ML; Hørslev-Petersen K; Hornung N; Poulsen JH; Flyvbjerg A; Stengaard-Pedersen K
J Rheumatol; 2009 Sep; 36(9):1885-91. PubMed ID: 19684150
[TBL] [Abstract][Full Text] [Related]
32. Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy.
Mok MY; Lo Y; Chan TM; Wong WS; Lau CS
J Rheumatol; 2005 Apr; 32(4):609-15. PubMed ID: 15801014
[TBL] [Abstract][Full Text] [Related]
33. Safety of celecoxib in patients with adverse skin reactions to acetaminophen (paracetamol) and nimesulide associated or not with common non-steroidal anti-inflammatory drugs.
Liccardi G; Salzillo A; Piccolo A; Senna G; Piscitelli E; D'Amato M; D'Amato G
Eur Ann Allergy Clin Immunol; 2005 Feb; 37(2):50-3. PubMed ID: 15859361
[TBL] [Abstract][Full Text] [Related]
34. Adverse events with disease modifying antirheumatic drugs (DMARD): a cohort study of leflunomide compared with other DMARD.
Cannon GW; Holden WL; Juhaeri J; Dai W; Scarazzini L; Stang P
J Rheumatol; 2004 Oct; 31(10):1906-11. PubMed ID: 15468352
[TBL] [Abstract][Full Text] [Related]
35. Serum thrombomodulin in systemic lupus erythematosus and juvenile idiopathic arthritis.
el-Gamal YM; Heshmat NM; el-Kerdany TH; Fawzy AF
Pediatr Allergy Immunol; 2004 Jun; 15(3):270-7. PubMed ID: 15209962
[TBL] [Abstract][Full Text] [Related]
36. Low-dose prednisolone in rheumatoid arthritis: adverse effects of various disease modifying antirheumatic drugs.
Malysheva OA; Wahle M; Wagner U; Pierer M; Arnold S; Häntzschel H; Baerwald CG
J Rheumatol; 2008 Jun; 35(6):979-85. PubMed ID: 18412314
[TBL] [Abstract][Full Text] [Related]
37. Cognitive impairment in patients with systemic lupus erythematosus.
Hanly JG; Fisk JD; Sherwood G; Jones E; Jones JV; Eastwood B
J Rheumatol; 1992 Apr; 19(4):562-7. PubMed ID: 1593578
[TBL] [Abstract][Full Text] [Related]
38. Treatment of psoriatic arthritis and rheumatoid arthritis with disease modifying drugs -- comparison of drugs and adverse reactions.
Helliwell PS; Taylor WJ;
J Rheumatol; 2008 Mar; 35(3):472-6. PubMed ID: 18203324
[TBL] [Abstract][Full Text] [Related]
39. Reproductive health in women with systemic lupus erythematosus compared to population controls.
Ekblom-Kullberg S; Kautiainen H; Alha P; Helve T; Leirisalo-Repo M; Julkunen H
Scand J Rheumatol; 2009; 38(5):375-80. PubMed ID: 19308803
[TBL] [Abstract][Full Text] [Related]
40. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus.
McLaurin EY; Holliday SL; Williams P; Brey RL
Neurology; 2005 Jan; 64(2):297-303. PubMed ID: 15668428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
